ANDA 74947, held by Pharmobedient. Clomipramine Hydrochloride.
As of Nov 16, 2026, ANDA 74947 (Clomipramine Hydrochloride), held by Pharmobedient, was first approved by FDA on Apr 30, 1998, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 30, 1998 | Original application | Approved |
| Clomipramine Hydrochloride25MG · capsule;oral | Clomipramine Hydrochloride | Discontinued |
| Clomipramine Hydrochloride50MG · capsule;oral | Clomipramine Hydrochloride | Discontinued |
| Clomipramine Hydrochloride75MG · capsule;oral | Clomipramine Hydrochloride | Discontinued |
| Dec 29, 2016 | Supplement 16Labeling · Standard review | Approved | None posted |
| Mar 18, 2013 | Supplement 15Labeling · Standard review | Approved | None posted |
| Oct 16, 2007 | Supplement 10Labeling | Approved | None posted |
| Jul 9, 2007 | Supplement 8Labeling | Approved | None posted |
| May 3, 2005 | Supplement 4Labeling | Approved | None posted |
| Oct 31, 2003 | Supplement 3Labeling | Approved | None posted |
| Dec 11, 2001 | Supplement 2Labeling | Approved | None posted |
| Aug 3, 2001 | Supplement 1Labeling | Approved | None posted |
| Apr 30, 1998 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters